HealthScienceTechnologyWorld

Global Rare Disease Diagnostics Market || keyplayers Strand Life Sciences Pvt Ltd. Eurofins Scientific Laboratory Corporation of America

Introduction:

A rare disease is normally considered to be a disease that affects less than 200,000 individuals in the U.S. Every nation have their official definitions of a rare disease. In the European Union, a disease affects fewer than 1 in 2,000 people which is defined as rare diseases. Rare diseases are also sometimes called orphan diseases. There is a group of around 6000-7000 life-threatening diseases affecting a small percentage of the population. Rare disease diagnosis includes an extensive range of diagnostic tests such as genetic tests, lab tests, imaging, physical examinations performed in diagnostic laboratories, hospitals, cancer research institutes, and others.

Drivers and Restraints:

The increasing patient pool for rare disease growth and growing support from the government to accelerate research in rare diseases, plus the interest of large pharmaceutical companies in manufacturing orphan drugs and orphan disease diagnostic devices are the major factor driving the growth of the target market. Also, pharmaceutical key players are investing in R&D for the development of innovative and better diagnostic devices for rare diseases. Moreover, an increase in awareness among people about rare diseases is also expected to drive the growth of the target market. Furthermore, the increasing initiatives by various organizations and governments of the nation to focus on research and development propels the growth of the target market. For instance, according to Genetic and Rare Diseases Information Center (GARD) – The National Institutes of Health (NIH) supports research to advance the health of people with rare diseases. Additionally, there are 27 Institutes and Centers at the NIH fund medical research for rare diseases. This technology aims to speed the growth of treatments that will finally serve both rare and common diseases, thus boosting the target market growth globally.

Request free sample:-https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/3838

 

  1. Global Rare Disease Diagnostics  Market, By Disease Type, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Gastroenterology Disease
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Endocrine and Metabolism Disorders
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Cardiovascular Disorders
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Neurology Disease
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Haematology and Oncology Disease
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Dermatology Disease Type
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Other Therapeutic Areas
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  2. Global Rare Disease Diagnostics  Market, By Test Type, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Genetic Test
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • General Lab Tests
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Imaging Test Type
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Other Tests
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  3. Global Rare Disease Diagnostics  Market, By Trait, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Inherited Trait Type
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Acquired Trait Type
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  4. Global Rare Disease Diagnostics  Market, By Age Group, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Children Age Group
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Adult Age Group
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  5. Global Rare Disease Diagnostics  Market, By End-user, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Hospital Laboratories
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Diagnostic laboratories
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Genetic Testing Laboratories
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Cancer Research Laboratories
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Other End User
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030

Company Profile:

  • Retrophin, Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Performance
  • 3billion, Inc.
  • 23andMe, Inc.
  • QIAGEN N.V.
  • Illumina Inc.
  • PerkinElmer, Inc.
  • BGI, Partek, Inc.
  • GENEWIZ
  • Centogene A.G.
  • Strand Life Sciences Pvt Ltd.
  • Eurofins Scientific
  • Laboratory Corporation of America

Contact Us:

Mr. Alex (Sales Manager)

Prophecy Market Insights

Phone: +1 860 531 2701

+91 777 504 9802
Email: sales@prophecymarketinsights.com

Back to top button